Limitations of Anti-Angiogenic Treatment of Tumors
Sign Up to like & getrecommendations! Published in 2019 at "Translational Oncology"
DOI: 10.1016/j.tranon.2019.04.022
Abstract: Clinical trials using anti-vascular endothelial growth factor /(VEGF) molecules induce a modest improvement in overall survival, measurable in weeks to just a few months, and tumors respond differently to these agents. In this review article,… read more here.
Keywords: limitations anti; tumor; anti angiogenic; treatment tumors ... See more keywords